Institut de Recherche en Santé, Environnement et Travail, Faculté de Pharmacie, 2 Avenue Professeur Léon Bernard, 35043 Rennes, France.
Expert Opin Drug Metab Toxicol. 2012 Jan;8(1):29-46. doi: 10.1517/17425255.2012.637918. Epub 2011 Dec 19.
Membrane drug transporters are well recognized as important contributing factors to pharmacokinetics, notably involved in drug-drug interactions. Besides drugs, environmental chemicals, to which humans are commonly exposed, are also substrates, inhibitors or inducers of drug transporters, which may have notable consequences toward toxicokinetics, toxicity and pharmacokinetics.
This review summarizes key data about the interactions of main environmental contaminants with drug transporters, including the nature of drug transporters involved in contaminant transport, or inhibited or induced by these chemicals. Implications for toxicokinetics and toxicity of pollutants and pharmacokinetics of drugs administrated to pollutant-exposed humans are also discussed.
Although various structurally unrelated environmental chemicals have been already demonstrated to interact with drug transporters, further in vitro and in vivo studies are probably required to characterize pollutant-transporter interplays in a more extensive and accurate way. Data obtained should be next confronted with known exposure levels of humans to pollutants, with the aim to fully determine the relevance of environmental contaminant-transporter interactions in terms of toxicokinetics, toxicity and putative pollutant-drug interactions.
膜药物转运体是公认的药代动力学的重要影响因素,特别是在药物-药物相互作用中。除了药物之外,人类通常接触的环境化学物质也是药物转运体的底物、抑制剂或诱导剂,这可能对毒代动力学、毒性和药物代谢动力学产生显著影响。
本综述总结了主要环境污染物与药物转运体相互作用的关键数据,包括参与污染物转运的药物转运体的性质,或这些化学物质对其的抑制或诱导。还讨论了污染物对毒代动力学和毒性以及暴露于污染物的人群中给予药物的药物代谢动力学的影响。
尽管已经证明各种结构上不相关的环境化学物质与药物转运体相互作用,但可能需要进一步的体外和体内研究,以更广泛和准确的方式描述污染物-转运体相互作用。接下来应该将获得的数据与人类已知的污染物暴露水平进行比较,目的是根据毒代动力学、毒性和潜在的污染物-药物相互作用,充分确定环境污染物-转运体相互作用的相关性。